Calls For Cough/Cold Collaboration As FDA Inches Toward Rulemaking

As FDA embarks on a lengthy rulemaking process to address pediatric OTC cough/cold products, the agency has strategies outside the regulatory framework available to effect any more immediate changes it deems necessary